Literature DB >> 17446

Megaloblastic anaemia associated with sulphasalazine treatment.

R E Schneider, L Beeley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 17446      PMCID: PMC1607743          DOI: 10.1136/bmj.1.6077.1638

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Effect of sulfasalazine on digoxin bioavailability.

Authors:  R P Juhl; R W Summers; J K Guillory; S M Blaug; F H Cheng; D D Brown
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

2.  Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors:  J R Collins
Journal:  South Med J       Date:  1968-04       Impact factor: 0.954

3.  Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine).

Authors:  J L Franklin; H H Rosenberg
Journal:  Gastroenterology       Date:  1973-04       Impact factor: 22.682

  3 in total
  12 in total

1.  Megaloblastic anaemia associated with sulphasalazine treatment.

Authors:  S P Kane; M A Boots
Journal:  Br Med J       Date:  1977-11-12

2.  Salazopyrin in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; E P Butler; R A Crockson; A P Crockson; L Walsh
Journal:  Agents Actions       Date:  1978-06

Review 3.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 4.  Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.

Authors:  S B Hanauer; G Stathopoulos
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

5.  Salazopyrin in rheumatoid arthritis. 1978.

Authors:  B McConkey; R S Amos; E P Butler; R A Crockson; A P Crockson; L Walsh
Journal:  Agents Actions       Date:  1994-12

Review 6.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

7.  Role of sulphasalazine in the aetiology of folate deficiency in ulcerative colitis.

Authors:  C M Swinson; J Perry; M Lumb; A J Levi
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

8.  Sulphasalazine in rheumatoid arthritis.

Authors:  B McConkey; R S Amos; S Durham; P J Forster; S Hubball; L Walsh
Journal:  Br Med J       Date:  1980-02-16

9.  Sulphasalazine associated pancytopenia may be caused by acute folate deficiency.

Authors:  E C Logan; L M Williamson; D R Ryrie
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

10.  Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.

Authors:  M Dougados; P Boumier; B Amor
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.